297 related articles for article (PubMed ID: 32803716)
1. Poor outcomes in patients with cirrhosis and Corona Virus Disease-19.
Shalimar ; Elhence A; Vaishnav M; Kumar R; Pathak P; Soni KD; Aggarwal R; Soneja M; Jorwal P; Kumar A; Khanna P; Singh AK; Biswas A; Nischal N; Dar L; Choudhary A; Rangarajan K; Mohan A; Acharya P; Nayak B; Gunjan D; Saraya A; Mahapatra S; Makharia G; Trikha A; Garg P
Indian J Gastroenterol; 2020 Jun; 39(3):285-291. PubMed ID: 32803716
[TBL] [Abstract][Full Text] [Related]
2. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).
Sarin SK; Choudhury A; Lau GK; Zheng MH; Ji D; Abd-Elsalam S; Hwang J; Qi X; Cua IH; Suh JI; Park JG; Putcharoen O; Kaewdech A; Piratvisuth T; Treeprasertsuk S; Park S; Wejnaruemarn S; Payawal DA; Baatarkhuu O; Ahn SH; Yeo CD; Alonzo UR; Chinbayar T; Loho IM; Yokosuka O; Jafri W; Tan S; Soo LI; Tanwandee T; Gani R; Anand L; Esmail ES; Khalaf M; Alam S; Lin CY; Chuang WL; Soin AS; Garg HK; Kalista K; Batsukh B; Purnomo HD; Dara VP; Rathi P; Al Mahtab M; Shukla A; Sharma MK; Omata M;
Hepatol Int; 2020 Sep; 14(5):690-700. PubMed ID: 32623632
[TBL] [Abstract][Full Text] [Related]
3. High rates of 30-day mortality in patients with cirrhosis and COVID-19.
Iavarone M; D'Ambrosio R; Soria A; Triolo M; Pugliese N; Del Poggio P; Perricone G; Massironi S; Spinetti A; Buscarini E; Viganò M; Carriero C; Fagiuoli S; Aghemo A; Belli LS; Lucà M; Pedaci M; Rimondi A; Rumi MG; Invernizzi P; Bonfanti P; Lampertico P
J Hepatol; 2020 Nov; 73(5):1063-1071. PubMed ID: 32526252
[TBL] [Abstract][Full Text] [Related]
4. Effect of COVID-19 on patients with compensated chronic liver diseases.
Ji D; Zhang D; Yang T; Mu J; Zhao P; Xu J; Li C; Cheng G; Wang Y; Chen Z; Qin E; Lau G
Hepatol Int; 2020 Sep; 14(5):701-710. PubMed ID: 32734407
[TBL] [Abstract][Full Text] [Related]
5. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.
Marjot T; Moon AM; Cook JA; Abd-Elsalam S; Aloman C; Armstrong MJ; Pose E; Brenner EJ; Cargill T; Catana MA; Dhanasekaran R; Eshraghian A; García-Juárez I; Gill US; Jones PD; Kennedy J; Marshall A; Matthews C; Mells G; Mercer C; Perumalswami PV; Avitabile E; Qi X; Su F; Ufere NN; Wong YJ; Zheng MH; Barnes E; Barritt AS; Webb GJ
J Hepatol; 2021 Mar; 74(3):567-577. PubMed ID: 33035628
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China.
Li C; Chen Q; Wang J; Lin H; Lin Y; Lin J; Peng F; Chen J; Yang Z
Aging (Albany NY); 2020 Aug; 12(16):15938-15945. PubMed ID: 32855361
[TBL] [Abstract][Full Text] [Related]
7. Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis?
Lei JH; Peng F; Chen Z; Xiao XQ
BMC Infect Dis; 2019 Apr; 19(1):363. PubMed ID: 31039732
[TBL] [Abstract][Full Text] [Related]
8. Acute on chronic liver failure from novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Qiu H; Wander P; Bernstein D; Satapathy SK
Liver Int; 2020 Jul; 40(7):1590-1593. PubMed ID: 32369658
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea.
Lee YR; Kang MK; Song JE; Kim HJ; Kweon YO; Tak WY; Jang SY; Park JG; Lee C; Hwang JS; Jang BK; Suh JI; Chung WJ; Kim BS; Park SY
Clin Mol Hepatol; 2020 Oct; 26(4):562-576. PubMed ID: 33053932
[TBL] [Abstract][Full Text] [Related]
10. Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure.
Bernsmeier C; Cavazza A; Fatourou EM; Theocharidou E; Akintimehin A; Baumgartner B; Dhar A; Auzinger G; Thursz M; Bernal W; Wendon JA; Karvellas CJ; Antoniades CG; McPhail MJW
Aliment Pharmacol Ther; 2020 Sep; 52(5):855-865. PubMed ID: 32683724
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.
Mallet V; Beeker N; Bouam S; Sogni P; Pol S;
J Hepatol; 2021 Oct; 75(4):848-855. PubMed ID: 33992699
[TBL] [Abstract][Full Text] [Related]
12. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
[TBL] [Abstract][Full Text] [Related]
13. Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.
Chen T; Yang Z; Choudhury AK; Al Mahtab M; Li J; Chen Y; Tan SS; Han T; Hu J; Hamid SS; Huei LG; Ghazinian H; Nan Y; Chawla YK; Yuen MF; Devarbhavi H; Shukla A; Abbas Z; Sahu M; Dokmeci AK; Lesmana LA; Lesmana CRA; Xin S; Duan Z; Guo W; Ma K; Zhang Z; Cheng Q; Jia J; Sharma BC; Sarin SK; Ning Q
Hepatol Int; 2019 Nov; 13(6):695-705. PubMed ID: 31650510
[TBL] [Abstract][Full Text] [Related]
14. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study.
Satapathy SK; Roth NC; Kvasnovsky C; Hirsch JS; Trindade AJ; Molmenti E; Barish M; Hirschwerk D; Da BL; Bernstein D;
Hepatol Int; 2021 Jun; 15(3):766-779. PubMed ID: 33826042
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
17. Characteristics, predictors and outcomes among 99 patients hospitalised with COVID-19 in a tertiary care centre in Switzerland: an observational analysis.
Gregoriano C; Koch D; Haubitz S; Conen A; Fux CA; Mueller B; Bernasconi L; Hammerer-Lercher A; Oberle M; Burgermeister S; Reiter H; Kutz A; Schuetz P
Swiss Med Wkly; 2020 Jul; 150():w20316. PubMed ID: 32668007
[TBL] [Abstract][Full Text] [Related]
18. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.
Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jansen C; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Jarcuska P; Steib C; Reiberger T; Acevedo J; Gatti P; Shawcross DL; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Danielsen KV; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solé C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Kani HT; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia-Lopez E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Praktiknjo M; Curto A; Pitarch C; Putignano A; Moreno E; Bernal W; Aguilar F; Clària J; Ponzo P; Vitalis Z; Zaccherini G; Balogh B; Gerbes A; Vargas V; Alessandria C; Bernardi M; Ginès P; Moreau R; Angeli P; Jalan R; Arroyo V;
J Hepatol; 2021 May; 74(5):1097-1108. PubMed ID: 33227350
[TBL] [Abstract][Full Text] [Related]
19. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
